Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin
- 1 April 2001
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 418 (1-2) , 147-152
- https://doi.org/10.1016/s0014-2999(01)00928-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1β and TNF-α secretion following an in vivo lipopolysaccharide challengeLife Sciences, 2000
- Characterization of d-fenfluramine-induced hypothermia: evidence for multiple sites of actionEuropean Journal of Pharmacology, 2000
- An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in ratsImmunopharmacology, 2000
- Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the ratEuropean Journal of Pharmacology, 1999
- 3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humansNeuroscience & Biobehavioral Reviews, 1999
- Role of Serotonin in the Immune System and in Neuroimmune InteractionsBrain, Behavior, and Immunity, 1998
- MDMA induced dopamine release in vivo: role of endogenous serotoninJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Corticosterone-independent alteration of lymphocyte mitogenic function by amphetamineBrain, Behavior, and Immunity, 1992
- Effects of amphetamine on T-cell immune response in miceLife Sciences, 1991
- Stress and immunity: An integrated view of relationships between the brain and the immune systemLife Sciences, 1989